Methemoglobin levels greater than 50% induce comas, seizures, and death.[6] Methylene blue is used to treat symptomatic patients with methemoglobin levels greater than 20% or patients with risk factors, such as anemia or congestive heart failure. Here, HBG2 is linked to anemia (phenotype).